Insights from explainable AI in oesophageal cancer team decisions
Insights from explainable AI in oesophageal cancer team decisions
Background: clinician-led quality control into oncological decision-making is crucial for optimising patient care. Explainable artificial intelligence (XAI) techniques provide data-driven approaches to unravel how clinical variables influence this decision-making. We applied global XAI techniques to examine the impact of key clinical decision-drivers when mapped by a machine learning (ML) model, on the likelihood of receiving different oesophageal cancer (OC) treatment modalities by the multidisciplinary team (MDT).
Methods: retrospective analysis of 893 OC patients managed between 2010 and 2022 at our tertiary unit, used a random forests (RF) classifier to predict four possible treatment pathways as determined by the MDT: neoadjuvant chemotherapy followed by surgery (NACT + S), neoadjuvant chemoradiotherapy followed by surgery (NACRT + S), surgery-alone, and palliative management. Variable importance and partial dependence (PD) analyses then examined the influence of targeted high-ranking clinical variables within the ML model on treatment decisions as a surrogate model of the MDT decision-making dynamic.
Results: amongst guideline-variables known to determine treatments, such as Tumour-Node-Metastasis (TNM) staging, age also proved highly important to the RF model (16.1 % of total importance) on variable importance analysis. PD subsequently revealed that predicted probabilities for all treatment modalities change significantly after 75 years (p < 0.001). Likelihood of surgery-alone and palliative therapies increased for patients aged 75–85yrs but lowered for NACT/NACRT. Performance status divided patients into two clusters which influenced all predicted outcomes in conjunction with age.
Conclusion: XAI techniques delineate the relationship between clinical factors and OC treatment decisions. These techniques identify advanced age as heavily influencing decisions based on our model with a greater role in patients with specific tumour characteristics. This study methodology provides the means for exploring conscious/subconscious bias and interrogating inconsistencies in team-based decision-making within the era of AI-driven decision support.
Decision-making, Machine learning, Multidisciplinary teams, Oesophageal cancer
Thavanesan, Navamayooran
94f0a216-9131-431b-809c-f5a83146343d
Farahi, Arya
295bd2d0-e23f-460c-9eeb-c7825b2dddd2
Parfitt, Charlotte
74031046-3556-481c-9625-d917669e79cf
Belkhatir, Zehor
de90d742-a58f-4425-837c-20ff960fb9b6
Azim, Tayyaba
4e6decad-1e15-4e87-822c-70ca0ac8654a
Vallejos, Elvira Perez
865bfe8c-b577-4a7a-ab22-32635f22df9f
Walters, Zoë
e1ccd35d-63a9-4951-a5da-59122193740d
Ramchurn, Sarvapali
1d62ae2a-a498-444e-912d-a6082d3aaea3
Underwood, Timothy J.
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
Vigneswaran, Ganesh
4e3865ad-1a15-4a27-b810-55348e7baceb
Thavanesan, Navamayooran
94f0a216-9131-431b-809c-f5a83146343d
Farahi, Arya
295bd2d0-e23f-460c-9eeb-c7825b2dddd2
Parfitt, Charlotte
74031046-3556-481c-9625-d917669e79cf
Belkhatir, Zehor
de90d742-a58f-4425-837c-20ff960fb9b6
Azim, Tayyaba
4e6decad-1e15-4e87-822c-70ca0ac8654a
Vallejos, Elvira Perez
865bfe8c-b577-4a7a-ab22-32635f22df9f
Walters, Zoë
e1ccd35d-63a9-4951-a5da-59122193740d
Ramchurn, Sarvapali
1d62ae2a-a498-444e-912d-a6082d3aaea3
Underwood, Timothy J.
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
Vigneswaran, Ganesh
4e3865ad-1a15-4a27-b810-55348e7baceb
Thavanesan, Navamayooran, Farahi, Arya, Parfitt, Charlotte, Belkhatir, Zehor, Azim, Tayyaba, Vallejos, Elvira Perez, Walters, Zoë, Ramchurn, Sarvapali, Underwood, Timothy J. and Vigneswaran, Ganesh
(2024)
Insights from explainable AI in oesophageal cancer team decisions.
Computers in Biology and Medicine, 180, [108978].
(doi:10.1016/j.compbiomed.2024.108978).
Abstract
Background: clinician-led quality control into oncological decision-making is crucial for optimising patient care. Explainable artificial intelligence (XAI) techniques provide data-driven approaches to unravel how clinical variables influence this decision-making. We applied global XAI techniques to examine the impact of key clinical decision-drivers when mapped by a machine learning (ML) model, on the likelihood of receiving different oesophageal cancer (OC) treatment modalities by the multidisciplinary team (MDT).
Methods: retrospective analysis of 893 OC patients managed between 2010 and 2022 at our tertiary unit, used a random forests (RF) classifier to predict four possible treatment pathways as determined by the MDT: neoadjuvant chemotherapy followed by surgery (NACT + S), neoadjuvant chemoradiotherapy followed by surgery (NACRT + S), surgery-alone, and palliative management. Variable importance and partial dependence (PD) analyses then examined the influence of targeted high-ranking clinical variables within the ML model on treatment decisions as a surrogate model of the MDT decision-making dynamic.
Results: amongst guideline-variables known to determine treatments, such as Tumour-Node-Metastasis (TNM) staging, age also proved highly important to the RF model (16.1 % of total importance) on variable importance analysis. PD subsequently revealed that predicted probabilities for all treatment modalities change significantly after 75 years (p < 0.001). Likelihood of surgery-alone and palliative therapies increased for patients aged 75–85yrs but lowered for NACT/NACRT. Performance status divided patients into two clusters which influenced all predicted outcomes in conjunction with age.
Conclusion: XAI techniques delineate the relationship between clinical factors and OC treatment decisions. These techniques identify advanced age as heavily influencing decisions based on our model with a greater role in patients with specific tumour characteristics. This study methodology provides the means for exploring conscious/subconscious bias and interrogating inconsistencies in team-based decision-making within the era of AI-driven decision support.
Text
1-s2.0-S0010482524010631-main
- Version of Record
More information
Accepted/In Press date: 31 July 2024
e-pub ahead of print date: 5 August 2024
Additional Information:
For the purpose of open access, the authors have applied a Creative Commons attribution license (CC-BY) to any Author Accepted Manuscript version arising from this submission.
Keywords:
Decision-making, Machine learning, Multidisciplinary teams, Oesophageal cancer
Identifiers
Local EPrints ID: 493238
URI: http://eprints.soton.ac.uk/id/eprint/493238
ISSN: 0010-4825
PURE UUID: 53f3e139-0c04-45db-8c41-a542b0be4a57
Catalogue record
Date deposited: 28 Aug 2024 17:02
Last modified: 29 Aug 2024 02:01
Export record
Altmetrics
Contributors
Author:
Navamayooran Thavanesan
Author:
Arya Farahi
Author:
Charlotte Parfitt
Author:
Zehor Belkhatir
Author:
Tayyaba Azim
Author:
Elvira Perez Vallejos
Author:
Sarvapali Ramchurn
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics